Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors.
Pulmonology
; 2022 Apr 09.
Article
en En
| MEDLINE
| ID: mdl-35414494
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Pulmonology
Año:
2022
Tipo del documento:
Article